CGEM
Cullinan Oncology LLC
21.70$
+1.5%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -28.1% | -99.3% | +2,811.0% | +1,008,342.5% | +190.0% | +113.7% | +103.6% | +28.3% | -13.7% | +28.4% | -27.9% | |
| – | -50.2% | -98.1% | +2,811.0% | +996,086.3% | +192.5% | +112.1% | +39.7% | +60.0% | +1.2% | -13.6% | -6.7% | |
| – | -4.3% | -94.6% | -22.9% | +37,177,922.0% | +87.0% | +165.9% | -64.5% | +161.2% | -37.0% | -15.7% | +6.4% | |
| – | – | – | – | – | +191.5% | +113.1% | +38.2% | +60.9% | 0.0% | -14.6% | -5.3% | |
| – | -72.2% | – | – | – | – | – | – | – | – | -44.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -21.9% | -28.6% | -40.8% | +1,424.7% | – | – | – | |
| – | +12.1% | +8.1% | -53.5% | +9,461.0% | +153.9% | -89.7% | -17.9% | +120.9% | +16.1% | +4.0% | +25.9% | |
| – | +56.3% | +83.5% | +58.1% | +434.1% | +90.6% | +467.6% | -18.0% | +91.5% | +25.1% | +8.9% | +23.1% | |
| – | +9.6% | +2.1% | -69.6% | – | – | – | – | – | -9.9% | -9.6% | -40.1% | |
| – | +56.3% | +83.5% | +58.1% | +19.4% | +215.5% | +936.3% | -67.3% | -16.1% | -6.3% | -32.5% | -50.0% | |
| – | +9.6% | +2.1% | -69.6% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +113.5% | +25.9% | -15.2% | +30.1% | -30.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +27.2% | +4,175.1% | +1.8% | +5.3% | -10.9% | +29.4% | +9.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.